Citeline Podcasts

Europe’s Evolving Role in Global Clinical Trials

18 May 2026

Contributed by Lukas

As global clinical development strategies evolve, Europe is emerging as a critical hub for scientific innovation, operational agility, and patient rec...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 18, 2026

18 May 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年5月15日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - May 18, 2026

18 May 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended May 15, 2026. This episode was produced with the help of ...

Drug Fix: Post-Mortem On Martin Makary’s Tenure As FDA Commissioner

15 May 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs, as well as speci...

ABHI's Steve Lee on the UK MHRA's frictionless regulatory future for the UK

15 May 2026

Contributed by Lukas

The MHRA’s spring 2026 CE-marking consultation, the progress of UK medtech statutory instruments and the European Commission’s proposed revision o...

The Generics Bulletin Podcast: Biosimilars Conference Report And Big M&A Deals

14 May 2026

Contributed by Lukas

Generics Bulletin's editorial team discusses the recent Medicines for Europe biosimilars conference, attended by deputy editor Dean Rudge; while edito...

Kurma’s €215m Fund And What It Says About European Funding Environment

14 May 2026

Contributed by Lukas

Kurma Partners has closed BioFund IV at €215m — its largest fund to date, but roughly €35m short of its initial target. For partner Amanda Gett-...

Scrip Deals Podcast: An Interview With Jeremy Levin

14 May 2026

Contributed by Lukas

Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the v...

The Scrip Awards Podcast - Call For Entries 2026, New AI Category, Triana Interview

12 May 2026

Contributed by Lukas

Podcast: Inside Arcutis with CEO Frank Watanabe

12 May 2026

Contributed by Lukas

Arcutis Biotherapeutics' CEO Frank Watanabe joins In Vivo’s David Wild to talk about building a patient‑first culture and turning a three‑person...

How Agentic AI Could Reshape Consumer Health, With IQVIA’s Volker Spitzer

11 May 2026

Contributed by Lukas

In the latest episode of HBW Insight's Over the Counter podcast, Volker Spitzer, vice-president, global R&D/RWE services at IQVIA Consumer Health, ret...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 11, 2026

11 May 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年5月8日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip's Five Must-Know Things - May 11, 2026

11 May 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended May 8, 2026. This episode was produced with the help of A...

Drug Fix: US FDA’s Makary Pressured To Resign, Continues Hiring, Reform Efforts

08 May 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman and Editor-in-Chief Nielsen Hobbs consider the increasing pressure on US Fo...

Forum chief Gwyn Tudor puts the case for medtech development in Wales

08 May 2026

Contributed by Lukas

BioWales Podcast: Getting Medtech Right In A Small Country Maximizing The Tailwind From BioWales 2026 Gwyn Tudor, head of the MediWales forum, lays ou...

Drug Fix: The New Acting US FDA Biologics Center Director, SCOTUS Eyes Generic Drug Policy

01 May 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs and Generics Bulle...

Carna Health On Closing the Gap in CKD Prevention

30 Apr 2026

Contributed by Lukas

Blurb: Salvatore Viscomi, CEO and co-founder of Carna Health, discussed the company's pivotal work to combat the global crisis of chronic kidney disea...

What To Expect After China’s First siRNA Firm Went Public

30 Apr 2026

Contributed by Lukas

In this episode of the China biopharma English-language podcast, Xu Hu talks about the siRNA area, including possible industry and R&D environment cha...

Five-Minute Podcast: Chris Jones On Wales' Life Sciences Innovation Hub

28 Apr 2026

Contributed by Lukas

Genyro’s Adrian Woolfson on Artificial Biological Intelligence and Genome Writing

27 Apr 2026

Contributed by Lukas

In this In Vivo podcast, David Wild speaks with Adrian Woolfson, co-founder, president and CEO of Genyro, about how high-fidelity DNA writing and AI-d...

Cracking China's Consumer Health Market, With QIVA Global's Ellie Adams

27 Apr 2026

Contributed by Lukas

In the latest episode of the Over The Counter podcast, HBW Insight speaks with Ellie Adams, founder and CEO of QIVA Global – a strategy and operatin...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 27, 2026

27 Apr 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年4月24日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Apr. 27, 2026

27 Apr 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Apr. 24, 2026. This episode was produced with the help of...

PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗？(Chinese-language podcast)

24 Apr 2026

Contributed by Lukas

本期《中国生物技术播客》聚焦康方生物的依沃西单抗将如何改写历史，以及在PD-(L)1/VEGF双抗之间是否即将发生国...

Scrip M&A Podcast with Cooley Attorneys Kevin Cooper and Bill Roege.

22 Apr 2026

Contributed by Lukas

Scrip Senior Writer Joseph Haas interviewed attorneys Kevin Cooper and Bill Roegge of Cooley LLC about recent events and trends in biopharmaceutical m...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 21, 2026

21 Apr 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年4月17日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Apr. 21, 2026

21 Apr 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Apr. 17, 2026. This episode was produced with the help of...

The Generics Bulletin Podcast: Green Regulations With Medicines for Europe’s Adrian van den Hoven

20 Apr 2026

Contributed by Lukas

Generics Bulletin senior reporter Urtė Fultinavičiūtė speaks to Medicines for Europe’s director general Adrian van den Hoven about pertinent env...

Drug Fix: CBER Director Candidate Emerges, US FDA Promotes Leucovorin Pathway

17 Apr 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Senior Reporter Maaisha Osman and Editor-in-Chief Nielsen Hobbs discuss potenti...

성숙기 진입 중인 ADC 시장…삼성바이오에피스, 차별화 전략 강화 (Korean-language podcast) Apr. 17, 2026

17 Apr 2026

Contributed by Lukas

김윤철 삼성바이오에피스 상무는  Scrip과의 인터뷰에서 ADC 및 기타 신약개발 전략 등에 대해 이야기했습니다. 이...

Japan Q1 Roundup: Key Commercial and Policy/Regulatory Developments

17 Apr 2026

Contributed by Lukas

Join Scrip and The Pink Sheet's Tokyo-based team Lisa Takagi and Ian Haydock for a roundup of key commercial and policy/regulatory developments in Jap...

Lilly TuneLab: Breaking Data Silos in Biotech with Federated Learning

13 Apr 2026

Contributed by Lukas

How can small biotechs tap billion‑dollar AI models without giving up their data? David Wild talks with Eli Lilly's Aliza Apple about Lilly TuneLab,...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 10, 2026

13 Apr 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年4月10日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Apr. 13, 2026

13 Apr 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Apr. 10, 2026. This episode was produced with the help of...

Drug Fix: Leucovorin’s Resurrection, PhRMA’s Leadership Change

10 Apr 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss the details of the US Food an...

No Matter What: How Israel Is Positioning Itself as a Global Pharma Innovation Hub

08 Apr 2026

Contributed by Lukas

Israel has been a prolific source of biotech and AI-driven startups for years, but can it compete as a strategic R&D partner for global pharma? Mati G...

Inside Step Pharma’s Pan‑Cancer Ambition

07 Apr 2026

Contributed by Lukas

Andrew Parker, CEO at Step Pharma, outlined the company’s “pipeline in a product” strategy as it seeks to develop a targeted approach to blood c...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 6, 2026

06 Apr 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年4月03日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Apr. 6, 2026

06 Apr 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Apr. 3, 2026. This episode was produced with the help of ...

China Biopharma English-Language Podcast: China’s Regulatory Changes In Cell Therapy

03 Apr 2026

Contributed by Lukas

In this episode of the China biopharma English-language podcast, Xu Hu talks about recently China releasing two guidelines related to CAR-T therapies ...

Five-Minute Podcast: “UK Needs To Align More With The EU”

30 Mar 2026

Contributed by Lukas

A legal firm’s perspective on how the UK should evolve its medtech regulatory system, global harmonization and opportunities to embed best practice ...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 30, 2026

30 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月27当周的生物制药行业的商业动态。本期节目采用人工...

Why Longevity Is The Next Big OTC Opportunity, With Euromonitor’s Magda Starula

30 Mar 2026

Contributed by Lukas

In this episode of HBW Insight’s Over the Counter, we’re digging into one of the most talked‑about themes in consumer health right now: longevit...

Scrip's Five Must-Know Things - Mar.30, 2026

30 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.27, 2026. This episode was produced with the help ...

Drug Fix: US FDA Commissioner Martin Makary Completes First Year In Charge

27 Mar 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider US Food and Drug Administration Commi...

Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy

26 Mar 2026

Contributed by Lukas

Lupin’s CEO Vinita Gupta and managing director Nilesh Gupta speak with Citeline’s senior editor Vibha Ravi about their plans for first-in-class an...

Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy

25 Mar 2026

Contributed by Lukas

Lupin’s CEO Vinita Gupta and managing director Nilesh Gupta speak with Citeline’s senior editor Vibha Ravi about their plans for first-in-class an...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.23, 2026

23 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月20日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Mar.23, 2026

23 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.13, 2026. This episode was produced with the help of ...

Drug Fix: ACIP Next Steps After Judge Stops Work, Potential Opioid Disposal Changes

20 Mar 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, and Editor-in-Chief Nielsen Hobbs discuss the next steps after a feder...

How a CDMO Created a Custom Vaccine Development Project

19 Mar 2026

Contributed by Lukas

What does it take to move from concept to commercial vaccine manufacturing at speed without compromising quality or compliance? In this conversation, ...

뇌질환 신약 개발 펀딩 부활 조짐 (Korean-language podcast) Mar.19, 2026

19 Mar 2026

Contributed by Lukas

최근 미국의 BIO 투자자 및 성장 서밋에서 투자자들은 초기 단계 신경과학 분야의 자금 조달 환경이 여전히 어렵지...

The Generics Bulletin Podcast: 2026 Conferences

17 Mar 2026

Contributed by Lukas

The final week of February saw the AAM hold its Access! 2026 annual conference in Miami and Medicines for Europe hold its annual regulatory and scient...

Winning In The Probiotics Space, With David Pineda Ereño

16 Mar 2026

Contributed by Lukas

Probiotics remain one of the fastest‑growing segments in consumer health, but companies still face the challenge of operating in a fragmented claims...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.16, 2026

16 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月13日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Mar.16, 2026

16 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.13, 2026. This episode was produced with the help of ...

Drug Fix: US FDA’s Prasad Leaves, Harry Potter, And Is CNPV Effective Because Of RTOR?

13 Mar 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss potential directions for the ...

Killing Cancer Loudly: Onchilles Pharma's Neutrophil-Derived Path to Pan-Cancer Therapy

11 Mar 2026

Contributed by Lukas

What if a drug could kill cancer cells broadly, spare the immune system and then train it to keep fighting, without triggering resistance? That's the ...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.9, 2026

09 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月6日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip's Five Must-Know Things - Mar.9, 2026

09 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.6, 2026. This episode was produced with the help of A...

Drug Fix: The State Of Facility Inspections With Two Former Senior US FDA Execs

06 Mar 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery and Senior Editor Sue Sutter are joined by special guests Michael Rogers, former US Food and Drug Administ...

Unpacking Europe’s Probiotic Rules with David Pineda Ereño

02 Mar 2026

Contributed by Lukas

The European market for probiotic dietary supplements is one of the most dynamic, but also one of the most complicated, areas of self‑care right now...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 2, 2026

02 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月2日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip's Five Must-Know Things - Mar.2, 2026

02 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Feb.27, 2026. This episode was produced with the help of ...

Drug Fix: State Of The Generics Industry, US FDA Commissioner On Compassionate Use

27 Feb 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Editor-in-Chief Nielsen Hobbs and special guest Dave Wallace, executive editor of Generics Bulletin, disc...

Affibody and the Case for Antibody Mimetics in Radioligand Therapy

25 Feb 2026

Contributed by Lukas

Swedish biotech Affibody has spent over two decades engineering proteins 1/20th the size of a conventional monoclonal antibody — and CEO David Bejke...

글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026

25 Feb 2026

Contributed by Lukas

특허 만료와 미국 내 약가 압박은 대형 글로벌 제약사들이 극복해야 할 과제이며, 다수 제약사가 올해 소폭의 실적...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 24, 2026

24 Feb 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年2月20日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Feb.24, 2026

24 Feb 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended February 20, 2026. This episode was produced with the hel...

Drug Fix: ‘America First’ US FDA User Fees, Moderna’s Flu Vaccine Saga Continues

20 Feb 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss a ...

Hansa Biopharma On Clearing The Path To Kidney Transplant

16 Feb 2026

Contributed by Lukas

Renée Aguiar-Lucander, CEO of Hansa Biopharma, discussed the company’s leading asset, its journey toward US FDA approval and the trials and tribula...

ESG, Eco‑Pricing and Sustainable Packaging, with Steve Ramus

16 Feb 2026

Contributed by Lukas

In Part 2 of HBW Insight’s conversation with sustainability leader Steve Ramus, we dig into the practical realities shaping the future of sustainabi...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 16, 2026

16 Feb 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年2月13日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Feb.16, 2026

16 Feb 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended February 13, 2026. This episode was produced with the hel...

Drug Fix: US FDA Versus Moderna And The Changing Role Of Refuse To File Actions

13 Feb 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the...

Preventing Lung Disease in Preterm Babies

09 Feb 2026

Contributed by Lukas

Bronchopulmonary dysplasia affects up to 90% of extremely preterm infants, yet no approved therapies exist. In this episode of the In Vivo podcast, Ai...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 9 , 2026

09 Feb 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年2月6日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip's Five Must-Know Things - Feb. 9, 2026

09 Feb 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended February 60, 2026. This episode was produced with the hel...

Drug Fix: US FDA Hiring Improves, But Can The Agency Avoid Oversight Erosion?

06 Feb 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the impact of new data showing US Foo...

Navigating A Changing EU And US Sustainability Landscape, With Steve Ramus

02 Feb 2026

Contributed by Lukas

With the European Union rolling back parts of its Green Deal — including scaling back major legislation such as the Corporate Sustainability Reporti...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb.2, 2026

02 Feb 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年1月30日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Feb. 2, 2026

02 Feb 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended January 30, 2026. This episode was produced with the help...

Drug Fix: Understanding US FDA’s CNPV Application Reviews

30 Jan 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss details recently unearthed about the r...

How Senti Bio's Programmable Cell Therapy Tackles AML's Toxicity Problem

27 Jan 2026

Contributed by Lukas

Tim Lu, CEO of Senti Bio, joins In Vivo to discuss how programmable cell therapies are solving oncology's targeting problem. Lu explains the logic-gat...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

26 Jan 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年1月23日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Jan. 26, 2026

26 Jan 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended January 23, 2026. This episode was produced with the help...

Scrip JPM Podcast: Dealmaking, Regulatory And Commercial Expectations For 2026

23 Jan 2026

Contributed by Lukas

Scrip senior editor Jessica Merrill, Scrip US managing editor Mandy Jackson and In Vivo senior reporter David Wild discuss trends and topics from inte...

Drug Fix: US FDA Review Speed Steady In 2025, But Will Staffing Impact In 2026?

23 Jan 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs consider th...

Herantis’s ‘Elegant’ Approach In Parkinson’s

21 Jan 2026

Contributed by Lukas

Antti Vuolanto, CEO of Herantis Pharma, discusses the significant unmet need in Parkinson’s disease and outlines Phase II plans for the company’s ...

3分で解説 #世界のファーマ】第28回 ノバルティスが警鐘 自国第一主義の弊害へ (Japanese-language podcast)

19 Jan 2026

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

19 Jan 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年1月16日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Jan. 19, 2026

19 Jan 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended January 16, 2026. This episode was produced with the help...

Drug Fix: Pazdur’s CNPV Problems, Could US FDA Release Unapproved Product Action Packages?

16 Jan 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs consider the many concerns Richard Pazdur and...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

13 Jan 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年1月9日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip이 묻다: 2026년 바이오의약품 업계 전망은? 자본배분과 딜메이킹 (Korean-language podcast)

13 Jan 2026

Contributed by Lukas

Scrip의 2026년 글로벌 제약바이오 산업 전망 (1부: 자본배분과 딜메이킹)을 요약한내용입니다. https://insights.citeline....

Scrip's Five Must-Know Things - Jan. 13, 2026

13 Jan 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended January 9, 2026. This episode was produced with the help ...

Drug Fix: Oncology Stalwart Richard Pazdur Leaves US FDA

09 Jan 2026

Contributed by Lukas

PreVision Policy Founding Member Michael McCaughan joins Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nie...

Building a Nasal First line of Defense Against H5N1

05 Jan 2026

Contributed by Lukas

Intranasal vaccines are back in the spotlight as highly pathogenic avian influenza spreads among birds and spills over into mammals, including recent ...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

22 Dec 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月19日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Dec. 22, 2025

22 Dec 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended December 19, 2025. This episode was produced with the hel...